Pellieux and colleagues have demonstrated that overexpression of angiotensinogen in the heart induced maladaptive cardiac hypertrophy, associated with reduction of PPARα and enzymes of fatty acid metabolism, while glucose oxidation was unchanged [19]. The gene discussed is PPARA; the disease is cardiac hypertrophy.